Institute:
UNSW Australia
Recipient: Dr Daniel Carter
Funding: $296,428 July 2016 to June 2020

Despite aggressive therapy, the majority of children with high-risk neuroblastoma are incurable.
Neuroblastoma accounts for 15 per cent of all childhood cancer deaths, and only a half of high-risk patients survive their disease. Dr Daniel Carter and his team have newly identified a potential, novel therapeutic target - a protein called FACT which is found in these highly malignant tumours.

In this three-year project co-funded by The Kids’ Cancer Project and Cancer Australia, Dr Carter will investigate the role of FACT as a novel genetic driver of neuroblastoma. The research will focus on the mechanisms by which FACT can cause a normal cell to turn into cancer, and explore potential therapies that inhibit FACT in cancer cells. 

This project receives further support through Cancer Australia's Priority-driven Collaborative Cancer Research Scheme.
 

Donate to research and help find more effective treatments for kids with cancer.
Science is the solution for kids with cancer.
Donate today to give them better treatments.
Select your donation details
Please enter the amount you would like to donate

The Kids' Cancer Project is an ACNC Registered Charity 
ABN 13 061 138 181 | CFN 10581